Coronary Vascular Physiologic Simulation Software
FDA product code PJA · 8 cleared devices
Class 2
Cardiovascular
- Regulation
- 21 CFR 870.1415
- Review panel
- CV
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2016-01-13 – 2025-07-18
A coronary vascular physiologic simulation software device is intended to aid in the identification of functionally significant cardiovascular disease.
PJA
2025-07-18
PJA
2022-10-14
HeartFlow Analysis
View details →
PJA
2022-04-01
DEEPVESSEL FFR
View details →
PJA
2021-01-08
HeartFlow Analysis
View details →
PJA
2019-08-15
HeartFlow FFRct Analysis
View details →
PJA
2018-12-06
FFRct
View details →
PJA
2016-08-24
FFRct
View details →
PJA
2016-01-13
FFRct
View details →No matching devices.
Advertisement